Form 4: Rapport Therapeutics Director Buys Shares

Sentiment:

Insider Transaction (Form 4)


Ramiro Sanchez, a Director of Rapport Therapeutics, Inc., purchased 3,600 shares of common stock on October 23, 2026 for $27.35 per share.

Summary

  • Open-market purchase: acquired 3,600 Common Stock at $27.35 ($98,478) on October 23, 2026; holds 3,600 after (Direct).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $98,478, committing personal capital to the stock.

Insider Transactions

Ramiro Sanchez — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-10-23Open-market purchaseCommon Stock3,600$27$98.5K3,600

Key Dates

DateDescription
2026-10-23Open-market purchase (3,600 shares)

Keywords

insider transaction, Form 4, RAPP, Rapport Therapeutics, Inc., bullish, Ramiro Sanchez

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.